Early initiation of PCSK9 inhibition in myocardial infarction could be EPIC for patient care

EuroIntervention. 2022 Dec 2;18(11):e865-e867. doi: 10.4244/EIJ-E-22-00047.
No abstract available

MeSH terms

  • Humans
  • Myocardial Infarction* / therapy
  • Patient Care
  • Proprotein Convertase 9*
  • Risk Factors

Substances

  • PCSK9 protein, human
  • Proprotein Convertase 9